Evolved Gene Editors Reach Previously Inaccessible DNA
The compact enzymes edited heart-disease genes in cultured cells, a research-stage step toward wider CRISPR reach.
Updated on Nov. 4, 2026 in Life Sciences
Rice University researchers used Sequence Display to evolve compact Cas9 variants that can target DNA sites previously out of reach for CRISPR editing. The research is published in Nature Communications and is at the research stage, not a shipped product.
Why it matters
Genes whose protospacer adjacent motifs (PAMs) are only weakly recognized are difficult to edit, which limits which parts of the genome CRISPR tools can reach. Evolving smaller Cas9 proteins to recognize these sequences widens that reach, and the team's approach found promising candidates within a week, a pace that prior efforts by other researchers did not match.
The study is a laboratory result in cultured cells showing that evolved SlugCas9 edited sites in the APOC3 and PCSK9 genes, changes linked to lower coronary heart disease risk. The team reported finding promising candidates within one week using Sequence Display, against prior efforts by other researchers that had little success. Whether these edits translate to living tissue or patients is not yet established.
The players
Rice University
A Houston private research university whose labs work across synthetic biology and gene-editing tools, where this evolved-Cas9 research was conducted.
Han Xiao
A Rice University researcher who led the team that evolved compact Cas9 variants using Sequence Display and AI-driven protein design.
National Institutes of Health
The U.S. federal biomedical research agency that partly funded the work and supports much of the country's CRISPR and genetic-medicine research.
U.S. Department of Defense
The federal department that partly funded the research, with an interest in biotechnology tools for national-security and health applications.
The details
CRISPR enzymes such as Cas9 cut DNA only where a short sequence called a PAM sits next to the target, and each PAM is two to six base pairs long. Sequence Display, the method Han Xiao's team used, generates large datasets that artificial intelligence then analyzes to identify the protein sequences best suited to a given job. The researchers applied this to a compact Cas9 called SlugCas9, evolving it to better recognize PAMs already present in the target genes.
Timeline
Within one week of starting, Xiao's team identified promising evolved Cas9 candidates using Sequence Display.
On November 4, 2026, the article describing the Nature Communications paper was published.
The Tech Race
Researchers across academic labs are working to expand which genome sites CRISPR-Cas9 can reach, and this Rice University approach offers a faster route than earlier efforts that struggled to evolve Cas9 variants for these PAMs. The result positions AI-assisted protein evolution as a competing method for widening the CRISPR editing range.
No product or treatment is available yet, and the evolved SlugCas9 has been tested only in cultured cells. Any clinical use would require further laboratory, animal, and regulatory work whose timeline the article does not state.
The takeaway
Watch for follow-up studies testing evolved SlugCas9 in living organisms, which would show whether the cultured-cell edits hold up in more complex systems. Track whether other labs adopt Sequence Display to evolve Cas9 variants for PAMs that have resisted earlier efforts.
Further reading
For more on the tools reshaping genetic research, explore Life Sciences coverage across Houston's research institutions.
Source note: This article includes information reported by Firstwordpharma.
